Your session is about to expire
← Back to Search
Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD
N/A
Waitlist Available
Led By Jeremy A Weingarten, MD
Research Sponsored by New York Presbyterian Brooklyn Methodist Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 and day 5
Summary
This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.
Eligible Conditions
- Chronic Obstructive Pulmonary Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 and day 5
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 and day 5
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Length of Stay
Secondary study objectives
Analysis of Change in Daily Sputum Production
Change in 6MWT Test
Difference in Bedside Spirometry
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acapella Vibratory PEP Therapy DeviceExperimental Treatment1 Intervention
Subject will use the device 3 times a day throughout hospital stay
Group II: Sham Acapella Vibratory PEP DevicePlacebo Group1 Intervention
Subject will use the sham device 3 times a day throughout hospital stay
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acapella Vibratory PEP Therapy Device plus usual care
2013
N/A
~100
Find a Location
Who is running the clinical trial?
New York Presbyterian Brooklyn Methodist HospitalLead Sponsor
19 Previous Clinical Trials
3,695 Total Patients Enrolled
Jeremy A Weingarten, MDPrincipal InvestigatorNew York Presbyterian Brooklyn Methodist Hospital